Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cruz-Correa

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Gastroenterology|July 17, 2012
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagusGary W Falk, Navtej S Buttar, Nathan R Foster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2026
Randomized, Double-blind, Placebo-controlled Trial of Meriva® (curcuminoids) as a Candidate Chemoprevention Agent for Gastric CarcinogenesisMaria Gonzalez-Pons, Ricardo L Dominguez, Eleazar E Montalvan-Sanchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2026
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid TumorsManish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
The New England Journal of Medicine|October 15, 2015
A Trial of Calcium and Vitamin D for the Prevention of Colorectal AdenomasJohn A Baron, Elizabeth L Barry, Leila A Mott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal AdenomaRobert E Schoen, Lisa A Boardman, Marcia Cruz-Correa, et al.
Nature Medicine|January 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trialAnna Morena D'Alise, Jason Willis, Fahriye Duzagac, et al.
NPJ Breast Cancer|August 20, 2021
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin AmericaJosef S Herzog, Yanin Chavarri-Guerra, Danielle Castillo, et al.
BMJ (Clinical Research Ed.)|May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialMiao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
A review of cancer in U.S. Hispanic populationsRobert W Haile, Esther M John, A Joan Levine, et al.
Plos Neglected Tropical Diseases|September 14, 2017
Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015Kay M Tomashek, Olga D Lorenzi, Doris A Andújar-Pérez, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Gastroenterology|July 17, 2012
A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagusGary W Falk, Navtej S Buttar, Nathan R Foster, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2026
Randomized, Double-blind, Placebo-controlled Trial of Meriva® (curcuminoids) as a Candidate Chemoprevention Agent for Gastric CarcinogenesisMaria Gonzalez-Pons, Ricardo L Dominguez, Eleazar E Montalvan-Sanchez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2026
Phase I Study of Telisotuzumab Adizutecan (Temab-A, ABBV-400), a Novel c-Met Antibody-Drug Conjugate, in Patients With Late-Line Colorectal Cancer and Advanced Solid TumorsManish R Sharma, John Powderly, Yasutoshi Kuboki, et al.
The New England Journal of Medicine|October 15, 2015
A Trial of Calcium and Vitamin D for the Prevention of Colorectal AdenomasJohn A Baron, Elizabeth L Barry, Leila A Mott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 9, 2023
Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal AdenomaRobert E Schoen, Lisa A Boardman, Marcia Cruz-Correa, et al.
Nature Medicine|January 16, 2026
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trialAnna Morena D'Alise, Jason Willis, Fahriye Duzagac, et al.
NPJ Breast Cancer|August 20, 2021
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin AmericaJosef S Herzog, Yanin Chavarri-Guerra, Danielle Castillo, et al.
BMJ (Clinical Research Ed.)|May 28, 2024
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialMiao-Zhen Qiu, Do-Youn Oh, Ken Kato, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2012
A review of cancer in U.S. Hispanic populationsRobert W Haile, Esther M John, A Joan Levine, et al.
Plos Neglected Tropical Diseases|September 14, 2017
Clinical and epidemiologic characteristics of dengue and other etiologic agents among patients with acute febrile illness, Puerto Rico, 2012-2015Kay M Tomashek, Olga D Lorenzi, Doris A Andújar-Pérez, et al.
Pageof 16